These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8818842)

  • 1. Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection.
    Girard AE; Cimochowski CR; Faiella JA
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():9-19. PubMed ID: 8818842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
    Girard D; Finegan SM; Dunne MW; Lame ME
    J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
    Girard AE; Cimochowski CR; Faiella JA
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():29-37. PubMed ID: 8396094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
    Figueira M; Fernandes P; Pelton SI
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo.
    Retsema JA; Girard AE; Girard D; Milisen WB
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():83-9. PubMed ID: 2154442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
    Treyaprasert W; Schmidt S; Rand KH; Suvanakoot U; Derendorf H
    Int J Antimicrob Agents; 2007 Mar; 29(3):263-70. PubMed ID: 17194570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological and pharmacokinetic properties of azithromycin (Zithromac), a novel 15-membered ring macrolide antibacterial agent].
    Matsunaga T
    Nihon Yakurigaku Zasshi; 2001 May; 117(5):343-9. PubMed ID: 11411344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
    Soriano F; Parra A; Cenjor C; Nieto E; García-Calvo G; Giménez MJ; Aguilar L; Ponte C
    J Infect Dis; 2000 Feb; 181(2):646-52. PubMed ID: 10669350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae.
    Sato T; Kawai Y; Matsuda H; Tateda K; Kimura S; Ishii Y; Yamaguchi K; Gotoh N
    J Antimicrob Chemother; 2011 Jul; 66(7):1547-54. PubMed ID: 21511823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discussions on PRSP and BLNAR].
    Tajima T; Meguro H; Akita H; Iwata T
    Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
    [No Abstract]   [Full Text] [Related]  

  • 14. Change in pneumococcal susceptibility to azithromycin during treatment for acute otitis media.
    Toltzis P; Dul M; Blumer J
    Pediatr Infect Dis J; 2007 Jul; 26(7):647-9. PubMed ID: 17596812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin.
    Bouchillon SK; Johnson JL; Hoban DJ; Stevens TM; Johnson BM
    J Antimicrob Chemother; 2005 Jul; 56(1):224-7. PubMed ID: 15890718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute otitis media caused by Streptococcus pyogenes in children.
    Segal N; Givon-Lavi N; Leibovitz E; Yagupsky P; Leiberman A; Dagan R
    Clin Infect Dis; 2005 Jul; 41(1):35-41. PubMed ID: 15937760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiologic effect of bovine cerebrospinal fluid and azithromycin against Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae.
    Destache CJ; Pakiz CB; Kersting K
    Pharmacotherapy; 1997; 17(5):985-9. PubMed ID: 9324186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection.
    Vallée E; Azoulay-Dupuis E; Pocidalo JJ; Bergogne-Bérézin E
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1412-7. PubMed ID: 1324644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacodynamics of azithromycin and roxithromycin with S. pyogenes and S. pneumoniae in a model that simulates in vitro pharmacokinetics in human tonsils.
    Firsov AA; Zinner SH; Vostrov SN; Kononenko OV; Portnoy YA; Shustova LV; Kadenatsi IB
    J Antimicrob Chemother; 2002 Jan; 49(1):113-9. PubMed ID: 11751774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.